Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
The Journal of Pathology
|
July 29, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma
Valerie Heong, Tuan Z Tan, Maiko Miwa, et al.
Oncotargets and Therapy
|
July 8, 2021
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report
Manavi Sachdeva, Natalie Y L Ngoi, Diana Lim, et al.
Journal of Gynecologic Oncology
|
April 12, 2024
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience
Silvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, et al.
Cancers
|
June 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
Valerie Heong, Darwin Tay, Shane Ee Goh, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma
Je Lin Sieow, Hweixian Leong Penny, Sin Yee Gun, et al.
Developmental Cell
|
March 5, 2026
Multiscale mechanisms driving tissue rupture by invading cells
Selwin K Wu, Fuqiang Sun, Celestine Z Ho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2020
Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01)
Natalie Y L Ngoi, Valerie Heong, Johann I Tang, et al.
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2025
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trial
Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu, et al.
Cell Reports
|
September 1, 2021
GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility
Dawn Sijin Nin, Caryn Wujanto, Tuan Zea Tan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
The Journal of Pathology
|
July 29, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma
Valerie Heong, Tuan Z Tan, Maiko Miwa, et al.
Oncotargets and Therapy
|
July 8, 2021
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report
Manavi Sachdeva, Natalie Y L Ngoi, Diana Lim, et al.
Journal of Gynecologic Oncology
|
April 12, 2024
Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience
Silvana Talisa Wijaya, Natalie Yl Ngoi, Jerold Wz Loh, et al.
Cancers
|
June 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
Valerie Heong, Darwin Tay, Shane Ee Goh, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma
Je Lin Sieow, Hweixian Leong Penny, Sin Yee Gun, et al.
Developmental Cell
|
March 5, 2026
Multiscale mechanisms driving tissue rupture by invading cells
Selwin K Wu, Fuqiang Sun, Celestine Z Ho, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2020
Phase 1 Study of Low-Dose Fractionated Whole Abdominal Radiation Therapy in Combination With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer (GCGS-01)
Natalie Y L Ngoi, Valerie Heong, Johann I Tang, et al.
Nature Genetics
|
May 6, 2014
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2025
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trial
Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu, et al.
Cell Reports
|
September 1, 2021
GAGE mediates radio resistance in cervical cancers via the regulation of chromatin accessibility
Dawn Sijin Nin, Caryn Wujanto, Tuan Zea Tan, et al.
Page
of 6